Calcium Dobesilate Dispersible Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20080288
Indications:
1. Treatment of microangiopathy
Diabetic microangiopathy - retinopathy and glomerulosclerosis (Kimmelstiel-Wilson syndrome).
Non-diabetic microangiopathy - microangiopathy induced by sudden or long-term use of coumarin derivative cell inhibitors, oral contraceptives, or other drugs.
Microcirculatory disorders associated with chronic organic diseases (such as hypertension, arteriosclerosis, and cirrhosis).
2. Treatment of varicose vein syndrome
Primary varicose veins - pain, leg pain, myalgic cramps, paresthesia, acrocyanosis, purpuric dermatitis.
Varicose vein status - chronic venous insufficiency (CVI), phlebitis and superficial thrombophlebitis, thrombotic syndrome, varicose ulcers, pregnancy varicose veins.
3. Treatment of venous insufficiency accompanied by microcirculatory disorders
-Hemorrhoid syndrome
-Varicose veins
4. Adjunctive treatment for vein stripping and vein sclerosis
Treatment of postoperative syndrome, edema, and tissue infiltration.
Administration:
To be swallowed with meals or dispersed in warm water before intake.
Diabetic Retinopathy:
2 tablets per dose, 3 times daily (morning, noon, and evening).
Other Indications:
2 tablets per dose, twice daily (morning and evening). If clinical symptoms improve, the evening dose may be omitted (typically after approximately one month of medication).
(Note: This translation strictly follows the original Chinese text structure while using natural pharmaceutical English expressions. Parentheses are retained as per the original formatting. The translation maintains all dosage instructions and timing specifications without simplification.)
Specifications:
0.25g (calculated as C12H10CaO10S2
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.